Sponsor

The Deutsche Diabetes Forschungsgesellschaft e.V.

Clinical research sponsor

Published trials2

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

2 shown

Effects of GABAA Receptor Modulation by AP-325 on Insulin Secretion in Patients with Type 2 DiabetesNCT05160272 · lead sponsor · 2022-01-07

COMPLETED

Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 DiabetesNCT02637973 · lead sponsor · 2015-12-01

COMPLETED

Sponsor roles

lead sponsor2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.